Metformin tied to longer prostate cancer survival

By Veronica Hackethal, MD NEW YORK (Reuters Health) - In older men with diabetes and prostate cancer, taking the diabetes drug metformin was linked to a lower risk of death, according to a new study. Researchers found metformin's apparent benefits accumulated over time. Among men with diabetes in Ontario, Canada, who were over age 66, the study found a 24 percent reduction in prostate-cancer mortality for every six months of metformin use, and a similarly lower risk of death from any cause for the first six months. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/metformin-tied-longer-prostate-cancer-survival-202129248.html